Cardiac Resynchronization is Associated with Reduction in the Rate of ICD Therapies, While Improves Ventricular Function

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare:

For permissions and non-commercial reprint enquiries, please visit to start a request.

For author reprints, please email
Average (ratings)
No ratings
Your rating



Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

Young Investigator Award
Topic: 3. Heart Failure and Cardiomyopathy



Once ICD has been implanted, device therapies worsen prognosis.


CRT-D may reduce number of first appropriate ICD therapy, and independent factors can be identified.


175 consecutive patients (age 64.6±10.4 years, 23 [13.1 %] women), left ventricular ejection fraction (LVEF) 27.9 ± 7.6 % (range 10-50 %), 97 of ischemic origin, were treated, according to standard indications, with an ICD (in 80 cases the device was CRT-D) and followed-up during 2.5±1.5 years. Devices were placed for either primary (n=95) or secondary prevention (n=80).


44 (25.1 %) patients received at least one appropriate therapy, 11.55 (8.57-15.57) per 100 patient-years. In the multivariable analysis, indication for secondary prevention was associated with a higher risk of first appropriate therapy (HR 3.42 [1.36-8.57] p=0.009), and CRT-D was associated to a lower risk of first therapy (0.31 [0.11-0.88] p=0.027). This reduction was present across all subgroups, even in patients in primary prevention (p=0.05), and although patients treated with CRT-D had significant lower ejection fraction and poorer NYHA class that their counterparts. In the follow-up, LVEF in patients with CRT-D improved from 25.3 % (5.6) to 37.0 % (5.6) (p=0.001). There were no differences in mortality in patients with and without CRT.

Rate of ICD therapies

Article image


Although patients receiving CRT-D have a worse clinical profile, they receive less device therapies in comparison to those receiving an ICD; this reduction is associated with significant improvement in LV function.


  1. Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG. Impact of upgrade cardiac resynchronization therapy on ventricular arrhythmia frecuency in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2005;46:2258–63.
    Crossref | PubMed
  2. Manfredi JA, Al-khatib SM, Shaw LK, Thomas L, Fogel RI, Padanilam B, Rardon D, Vatthyam R, Gemma LW, Golden K, Prystowsky EN. Association between left ventricular ejection fraction post-cardiac resyncronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):257-64.
    Crossref | PubMed